Gilead Sciences (GILD)
(Real Time Quote from BATS)
$66.70 USD
-0.33 (-0.49%)
Updated Apr 24, 2024 11:28 AM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC4/25/24 |
---|---|
Current Quarter | -1.14 |
EPS Last Quarter | 1.72 |
Last EPS Surprise | -2.27% |
ABR | 2.24 |
Earnings ESP
|
-31.57% |
---|---|
Current Year | 4.52 |
Next Year | 7.26 |
EPS (TTM) | 6.72 |
P/E (F1) | 14.82 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.33B | 6.77B | 27.50B | 28.06B |
# of Estimates | 10 | 10 | 10 | 10 |
High Estimate | 6.78B | 6.87B | 27.88B | 28.86B |
Low Estimate | 6.15B | 6.56B | 27.29B | 27.44B |
Year ago Sales | 6.35B | 6.60B | 27.12B | 27.50B |
Year over Year Growth Est. | -0.32% | 2.57% | 1.41% | 2.06% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.14 | 1.61 | 4.52 | 7.26 |
# of Estimates | 8 | 10 | 10 | 12 |
Most Recent Consensus | 1.38 | 1.69 | 6.86 | 7.22 |
High Estimate | 1.38 | 1.78 | 7.15 | 7.79 |
Low Estimate | -1.74 | 1.40 | 3.55 | 6.61 |
Year ago EPS | 1.37 | 1.34 | 6.72 | 4.52 |
Year over Year Growth Est. | -183.21% | 20.15% | -32.74% | 60.67% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 3 | 3 | 4 | 1 |
Down Last 30 Days | 7 | 6 | 8 | 5 |
Down Last 60 Days | 7 | 6 | 8 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.14 | 1.61 | 4.52 | 7.26 |
7 Days Ago | 0.08 | 1.63 | 5.84 | 7.32 |
30 Days Ago | 1.56 | 1.66 | 7.08 | 7.50 |
60 Days Ago | 1.56 | 1.66 | 7.08 | 7.50 |
90 Days Ago | 1.76 | 1.78 | 7.41 | 7.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.50 | 1.60 | 3.90 | 7.11 |
Zacks Consensus Estimate | -1.14 | 1.61 | 4.52 | 7.26 |
Earnings ESP | -31.57% | -0.72% | -13.73% | -2.09% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.72 | 2.29 | 1.34 | 1.37 | NA |
Estimate | 1.76 | 1.91 | 1.60 | 1.63 | NA |
Difference | -0.04 | 0.38 | -0.26 | -0.26 | -0.05 |
Surprise | -2.27% | 19.90% | -16.25% | -15.95% | -3.64% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more